hotspot -WSS

hotspot

author：comprehensive 2025-09-30 01:01:49 - browse：3

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Study: AI not yet building 'n

WSS

Brain worms: The science behind RFK Jr.'s parasitic infection

Making AI in medicine accessible to smaller, and rural hospitals

The system is set up to fail children with medical complexity

Apple Watch's A

Steward Health Care files for bankruptcy

Study: AI not yet building 'n

focus

hotspot

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Readers discuss the intersection of pregnancy and addiction

Affirmative action in medical school literally saved lives

'Essentially witchcraft:' A former naturopath takes on the field

Medicare details structure of new drug price negotiation program

5 takeaways from STAT's examination of Zynex Medical

New air purifier tech could be key to improving indoor air quality

Medicare says breakthrough device reimbursement rule to come by summer

23andMe had bad news about my health. I wish a person had delivered it

Lilly's Alzheimer's drug donanemab backed by FDA advisers

hotspot

H5N1 communication has been strictly for the birds

H5N1 communication has been strictly for the birds

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Statins may not be needed by millions of people, study suggests

Researchers on aging grapple with how to calculate biological age

NIH tests clinical research in primary care with $30 million program

focus

hotspot

hotspot

leisure time